- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.11.25 | AstraZeneca to Invest $2B in Maryland | ||
| 21.11.25 | AGC Biologics Enters Gene Therapy Manufacturing Agreement with AAVantgarde | ||
| 20.11.25 | Novartis to Create New Flagship Manufacturing Hub in North Carolina | ||
| 20.11.25 | ProFound Therapeutics, Quotient Therapeutics Enter Collaborations with GSK | ||
| 19.11.25 | Piramal's Grangemouth, UK Facility Receives Updated MHRA GMP Certificates | ||
| 19.11.25 | Lilly to Open Lilly Gateway Labs Site in Philadelphia | ||
| 19.11.25 | Alkermes Ups Bid for Avadel to $2.37 Billion After Rival Offer | ||
| 19.11.25 | Primerdesign Launches Exsig Mag RapidBead Pro Extraction Kit | ||
| 19.11.25 | EC Approves Subcutaneous Administration of Keytruda | ||
| 19.11.25 | AGC Biologics, Repair Biotechnologies Partner to Develop & Manufacture mRNA Therapeutic | ||
| 18.11.25 | Johnson & Johnson 3Q Results | ||
| 18.11.25 | Agenus Taps Dr. José Iglesias as Chief Medical Affairs Officer | ||
| 18.11.25 | Halozyme Therapeutics Acquires Elektrofi for $750M | ||
| 18.11.25 | BioDuro Launches Peptide Business Unit | ||
| 18.11.25 | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia | ||
| 18.11.25 | Debiopharm Launches IDEAL Japan Initiative | ||
| 18.11.25 | European Commission Approves Remsima IV Liquid Formulation | ||
| 17.11.25 | Solve Therapeutics Raises $120M in Latest Funding Round | ||
| 17.11.25 | Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences | ||
| 17.11.25 | Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab | ||
| 17.11.25 | AdvanCell Appoints Philina Lee as CEO | ||
| 17.11.25 | Polpharma Biologics Launches Tyruko in the U.S. | ||
| 17.11.25 | Sonoma Biotherapeutics Names Stephen Dilly as CEO | ||
| 14.11.25 | Merck 3Q Results | ||
| 14.11.25 | Pfizer 3Q Results |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .